Category - Pharma Leaders
Pharmaceutical Executive: April 2025 Interactive Digital Edition
FDA Grants Priority Review to Regeneron’s Eylea for Macular Edema Following Retinal Vein Occlusion
Regeneron, Sanofi Get FDA Approval for Dupixent to Treat Chronic Spontaneous Urticaria
Using RWD to Create Personalized Engagement
Sanofi Advances Mid- to Late-Stage Respiratory Pipeline, Targeting Unmet Need in Asthma, COPD
Understanding Chronic Inflammation Through Viral Exposure
Chrissy Teigen Joins Sanofi Campaign for Early Diabetes Testing
Using AI and RWD to Drive Creative Decision-Making